1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Vancomycin-Resistant Enterococcus Faecium Infections Global Clinical Trials Review, H2, 2015

Vancomycin-Resistant Enterococcus Faecium Infections Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Vancomycin-Resistant Enterococcus Faecium Infections Global Clinical Trials Review, H2, 2015" provides an overview of Vancomycin-Resistant Enterococcus Faecium Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Vancomycin-Resistant Enterococcus Faecium Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Vancomycin-Resistant Enterococcus Faecium Infections Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Vancomycin-Resistant Enterococcus Faecium Infections to Infectious Disease Clinical Trials 13
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Vancomycin-Resistant Enterococcus Faecium Infections to Infectious Disease Clinical Trials 17
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics Clinical Trials 27
Prominent Drugs 29
Clinical Trial Profile Snapshots 30
Appendix 42
Abbreviations 42
Definitions 42
Research Methodology 43
Secondary Research 43
About GlobalData 44
Contact Us 44
Disclaimer 44
Source 45

List of Tables
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, Global, Clinical Trials by Region, 2015* 6
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Proportion of Vancomycin-Resistant Enterococcus Faecium Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 14
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Vancomycin-Resistant Enterococcus Faecium Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29

List of Figures
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Proportion of Vancomycin-Resistant Enterococcus Faecium Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 13
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16
Proportion of Vancomycin-Resistant Enterococcus Faecium Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 17
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Vancomycin-Resistant Enterococcus Faecium Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 29
GlobalData Methodology 43

Companies Mentioned
Alvogen, Inc.
Pfizer Inc.
MicuRx Pharmaceuticals, Inc.
LegoChem Biosciences, Inc
CPR Pharma Services Pty Ltd
Allergan Plc

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Benzyl Alcohol Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Benzyl Alcohol Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • August 2016
  • by Transparency Market Research

Benzyl alcohol is an aromatic alcohol, which is metabolized into benzoic acid inthe human body. Benzyl alcohol is manufactured by hydrolysis of benzyl chloride in the presence of soda ash through the toluene ...

Asia-Pacific Animal Health Market - Forecast to 2021

Asia-Pacific Animal Health Market - Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The APAC animal health market is estimated to grow at a CAGR of 5.7% during the forecast period, to reach USD 20.25 billion by 2021 from USD 15.32 billion in 2016. Growth in this market can primarily be ...

Silver Sulfadiazine Market: By Application (Wound Care, Burn Care, Skin Care, UTIs) & By Geography -Forecast (2016-2021)

Silver Sulfadiazine Market: By Application (Wound Care, Burn Care, Skin Care, UTIs) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Silver sulfadiazine is an antibacterial drug used for making personal care products. Silver sulfadiazine is listed as the essential medicines by World Health Organization and is widely used as an antibiotic ...

Global Feed Antibiotics Market

October 2016 $ 4250

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.